FIA
CVAC

FNY Investment Advisers’s CureVac CVAC Stock Holding History

FNY Investment Advisers’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-700
Closed -$24K – 772
2021
Q4 		$24K Buy
+700
New +$28.2K 0.01% 322
2021
Q3 		– Sell
-1,000
Closed -$73K – 745
2021
Q2 		$73K Buy
+1,000
New +$100K 0.03% 342

Other funds holding CVAC

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

FNY Investment Advisers's CVAC Position: Q1 2022 in Review

FNY Investment Advisers sold out of CureVac (CVAC) in Q1 2022, closing a stake of 700 shares — an estimated $24K sold.

FNY Investment Advisers first reported a position in CVAC in Q2 2021 and held it in 2 quarters. The position peaked at $73K in Q2 2021. 111 funds tracked by Wall St. Rank hold CVAC as of Q1 2022.

  • FNY Investment Advisers reported no remaining CureVac position as of Q1 2022 after selling out during the quarter.
  • FNY Investment Advisers sold 700 CureVac shares in Q1 2022, an estimated $24K.
  • FNY Investment Advisers first reported a position in CureVac in Q2 2021 and held it in 2 quarters.
  • FNY Investment Advisers's CureVac position peaked at $73K in Q2 2021.
  • 111 funds tracked by Wall St. Rank held CureVac as of Q1 2022.

Based on FNY Investment Advisers's 13F filing for Q1 2022, filed 25 Apr 2022.